Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic lymphocytic leukemia treatment algorithm 2022
Paul J. Hampel, Sameer A. Parikh
Blood Cancer Journal (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

ACQUIRED MUTATIONS IN PATIENTS WITH RELAPSED/REFRACTORY CLL WHO PROGRESSED IN THE ALPINE STUDY
Jennifer R. Brown, Jessica Li, Barbara Eichhorst, et al.
Blood Advances (2025)
Open Access | Times Cited: 1
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia
Valentina Griggio, Candida Vitale, Maria Chiara Todaro, et al.
Haematologica (2019) Vol. 105, Iss. 4, pp. 1042-1054
Open Access | Times Cited: 46
Cause‐Specific Mortality and Prognostic Impact of Comorbidity in Japanese Patients With Chronic Lymphocytic Leukemia
Daisuke Ikeda, Takuya Nunomura, Tsuyoshi Muta, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
Jennifer R. Brown, John F. Seymour, Wojciech Jurczak, et al.
New England Journal of Medicine (2025) Vol. 392, Iss. 8, pp. 748-762
Closed Access
Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings
Nalan Alan Selçuk, Gamze Beydağı, Kaan Akçay, et al.
Molecular Imaging and Radionuclide Therapy (2025) Vol. 34, Iss. 1, pp. 31-37
Open Access
Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)
Nouman Aziz, Waseem Nabi, Muzamil Khan, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia
Rachel J. Bubik, Monica I. Aasum, Linda M. Tamminga, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Jennifer Edelmann, Karlheinz Holzmann, Eugen Tausch, et al.
Haematologica (2019) Vol. 105, Iss. 5, pp. 1379-1390
Open Access | Times Cited: 36
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia – an update
Tadeusz Robak, Anna Puła, Marcin Braun, et al.
Annals of Hematology (2024) Vol. 103, Iss. 9, pp. 3369-3383
Open Access | Times Cited: 3
Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option
Stefano Molica, Constantine S. Tam, David Allsup, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3737-3737
Open Access | Times Cited: 8
Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care
Mary Ann Anderson, Renata Walewska, Fidelma Hackett, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 980-980
Open Access | Times Cited: 2
Combined Delivery of miR-15/16 through Humanized Ferritin Nanocages for the Treatment of Chronic Lymphocytic Leukemia
Francesca Romana Liberati, Sara Di Russo, Lorenzo Barolo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 402-402
Open Access | Times Cited: 2
Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia
Simon Fifer, Jenni Godsell, Stephen Opat, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival
Flora Nguyen Van Long, Délya Valcourt‐Gendron, Patrick Caron, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 6
Malpractice Trends Involving Active Surveillance Across Cancers
Samuel Chang, Timothy J. Daskivich, Missael Vasquez, et al.
Annals of Surgery (2023)
Closed Access | Times Cited: 5
Real‐world comparative effectiveness of venetoclax‐obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia
Nilanjan Ghosh, Beenish S. Manzoor, Bita Fakhri, et al.
British Journal of Haematology (2024)
Open Access | Times Cited: 1
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis
Bryan Alexis Vallejo, Ahmed Ansari, Sameer A. Parikh, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 1
“Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies
Brian Vadasz, Taylor Zak, Jonathan Aldinger, et al.
Virchows Archiv (2024)
Closed Access | Times Cited: 1
MNK Proteins as Therapeutic Targets in Leukemia
Candice Mazewski, Leonidas C. Platanias
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 283-295
Open Access | Times Cited: 3
A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome
A. Wagner, Michèle Rouleau, Laurent Villeneuve, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 3
Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review
Maria Christina Cox, Fabiana Esposito, Massimiliano Postorino, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4440-4440
Open Access | Times Cited: 3
Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors
V.M. Shcherbina, Inna Gordiienko, L.M. Shlapatska, et al.
Experimental Oncology (2020) Vol. 42, Iss. 1, pp. 16-24
Open Access | Times Cited: 6
Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy
Timothy Woo, Matthew Carter, George Follows, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Carolina Alarcón-Payer, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 55-55
Open Access | Times Cited: 2
Cutaneous Plasmacytosis Complicated with Chronic Lymphocytic Leukemia: A Case Report
Ping Wang, † Le, Qiang Gong, et al.
Annals of Case Reports (2024) Vol. 9, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top